SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trickle Portfolio

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tnsaf who wrote (1746)9/1/2005 10:49:20 PM
From: tuck  Read Replies (1) of 1784
 
Stratagene loses patent infringement suit against Third Wave, but no news on the monetary damages:

MADISON, Wis., Sept. 1 /PRNewswire-FirstCall/ -- Third Wave Technologies Inc. (Nasdaq: TWTI - News) today announced that a federal jury has found Stratagene Corp. guilty of infringing patents that protect Third Wave's nucleic acid chemistry.

Third Wave in September 2004 filed suit against Stratagene in U.S. District Court alleging the infringement, seeking a permanent injunction preventing the sale of Stratagene's reagents marketed as "FullVelocity" products and monetary damages.

"The positive outcome of this trial for Third Wave and our shareholders solidifies and upholds the uniqueness of the Invader chemistry and strengthens the company's valuable intellectual property portfolio," said John Puisis, president and chief executive officer of Third Wave. "Many know that basic polymerase chain reaction, or PCR, the patents of which have expired, plus our Invader technology is more powerful than TaqMan and very valuable as a platform for nucleic acid testing. We own a powerful and valuable technology and will continue to vigorously protect it."

The Invader® chemistry and the methods of using it are protected by a suite of more than 45 issued patents; more than 100 additional Third Wave patents are pending.<<

snip

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext